-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Maintains Outperform on Abbott Laboratories, Lowers Price Target to $112

Benzinga·07/06/2026 15:09:30
Listen to the news
Evercore ISI Group analyst Vijay Kumar maintains Abbott Laboratories (NYSE:ABT) with a Outperform and lowers the price target from $120 to $112.